Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled amikacin for ventilator-associated pneumonia in mechanically ventilated patients with renal impairment
PACTR201909502649249Recruiting
- Sponsor
- Alexandria University Faculty of Medicine
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of amikacin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Alexandria University Faculty of Medicine. Primary endpoints: Response to antibiotic treatment and Pneumonia outcome. Started Sep 2019; status: recruiting.
02
Drugs
amikacin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on PACTR201909502649249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909502649249.